Cargando…

Insights into Facilitated Subcutaneous Immunoglobulin Use in Patients with Secondary Immunodeficiency Diseases: A FIGARO Subgroup Analysis

SIMPLE SUMMARY: The prospective, observation Facilitated Immunoglobulin Administration Registry And Outcomes (FIGARO) study was conducted to assess the clinical use and tolerability of facilitated subcutaneous immunoglobulin (fSCIG). In this report, final data for the cohort of patients with seconda...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dimou, Maria, Speletas, Matthaios, Milito, Cinzia, Pyzik, Aleksandra, Huscher, Dörte, Kamieniak, Marta, Pittrow, David, Borte, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526788/ https://www.ncbi.nlm.nih.gov/pubmed/37760493 http://dx.doi.org/10.3390/cancers15184524

Ejemplares similares

Facilitated Subcutaneous Immunoglobulin Treatment in Patients with Immunodeficiencies: the FIGARO Study
por: Borte, Michael, et al.
Publicado: (2023)

P1611: INSIGHTS INTO FACILITATED IMMUNOGLOBULIN (FSCIG) USE IN PATIENTS WITH SECONDARY IMMUNODEFICIENCY DISEASES: FINAL RESULTS FROM THE FIGARO STUDY
por: Dimou, M., et al.
Publicado: (2022)

Real-World Use, Safety, and Patient Experience of 20% Subcutaneous Immunoglobulin for Primary Immunodeficiency Diseases
por: Fasshauer, Maria, et al.
Publicado: (2023)

Hyaluronidase facilitated subcutaneous immunoglobulin in primary immunodeficiency
por: Jolles, Stephen
Publicado: (2013)

Figaro illustré.
Publicado: (1908)

El Fígaro : revista universal ilustrada.
Publicado: (1885)

Le nozze di Figaro = The marriage of Figaro : an opera in four acts
por: Mozart, Wolfgang Amadeus, 1756-1791
Publicado: (1990)

Subcutaneous Immunoglobulin Replacement Therapy in Patients with Primary Immunodeficiency in Routine Clinical Practice: The VISPO Prospective Multicenter Study
por: Vultaggio, Alessandra, et al.
Publicado: (2015)

Le nozze di Figaro Die Hochzeit des Figaro. KV 492 /

Fígaro : colección de artículos filosóficos, satíricos, literarios y políticos
por: Larra, Mariano José de, 1809-1837
Publicado: (1884)

Le nozze di Figaro
por: Mozart, Wolfgang Amadeus, 1756-1791
Publicado: (1990)

Le mariage de Figaro
por: Beaumarchais, Pierre Auguste Caron de, 1732-1799

Obras completas de Figaro
por: Larra, Mariano José de, 1809-1837
Publicado: (1848)

Le nozze di Figaro /
por: Mozart, Wolfgang Amadeus, 1756-1791
Publicado: (1982)

Le nozze di Figaro
por: Mozart, Wolfgang Amadeus, 1756-1791
Publicado: (1988)

Le nozze di Figaro
por: Mozart, Wolfgang Amadeus, 1756-1791
Publicado: (1968)

El casamiento de Fígaro
por: Beaumarchais, Pierre Aguste Caron de, 1732-1799
Publicado: (1947)

El casamiento de Fígaro /
por: Beaumarchais, Pierre Augustin Caron de, 1732-1799
Publicado: (1947)

Effects of Body Mass and Age on the Pharmacokinetics of Subcutaneous or Hyaluronidase-facilitated Subcutaneous Immunoglobulin G in Primary Immunodeficiency Diseases
por: Li, Zhaoyang, et al.
Publicado: (2023)

Efficacy and Safety of Hizentra(®), a New 20% Immunoglobulin Preparation for Subcutaneous Administration, in Pediatric Patients with Primary Immunodeficiency
por: Borte, Michael, et al.
Publicado: (2011)

New Frontiers in Subcutaneous Immunoglobulin Treatment
por: Jolles, Stephen, et al.
Publicado: (2011)

Figaro»: CERN-Forscher unter Terrorverdacht
Publicado: (2009)

Las bodas de Figaro; comedia en cinco actos,
por: Beaumarchais, Pierre Augustin Caron de, 1732-1799
Publicado: (1972)

Beaumarchais o las travesuras de Figaro
por: Fay, Bernard
Publicado: (1974)

Electronic Publishing in Academic Environments: The FIGARO Project
por: Bas Savenije
Publicado: (2002)

The FIGARO facility at Los Alamos: capabilties and first results
por: Haight, R C, et al.
Publicado: (2001)

Long-Term Tolerability, Safety, and Efficacy of Recombinant Human Hyaluronidase-Facilitated Subcutaneous Infusion of Human Immunoglobulin for Primary Immunodeficiency
por: Wasserman, Richard L., et al.
Publicado: (2016)

A clinician’s guide for administration of high-concentration and facilitated subcutaneous immunoglobulin replacement therapy in patients with primary immunodeficiency diseases
por: Epland, Kristin, et al.
Publicado: (2022)

Subcutaneous immunoglobulins replacement therapy in secondary antibody deficiencies: Real life evidence as compared to primary antibody deficiencies
por: Cinetto, Francesco, et al.
Publicado: (2021)

Subcutaneous immunoglobulin replacement therapy in the treatment of patients with primary immunodeficiency disease
por: Skoda-Smith, Suzanne, et al.
Publicado: (2010)

Is It Safe to Switch From Intravenous Immunoglobulin to Subcutaneous Immunoglobulin in Patients With Common Variable Immunodeficiency and Autoimmune Thrombocytopenia?
por: Scheuerlein, Philipp, et al.
Publicado: (2018)

Kidney outcomes with finerenone: an analysis from the FIGARO-DKD study
por: Ruilope, Luis M, et al.
Publicado: (2022)

Transitioning subcutaneous immunoglobulin 20% therapies in patients with primary and secondary immunodeficiencies: Canadian real-world study
por: Keith, Paul K., et al.
Publicado: (2022)

Subcutaneous immunoglobulin therapy: a new option for patients with primary immunodeficiency diseases
por: Kobrynski, Lisa
Publicado: (2012)

Initiation of immunoglobulin therapy by subcutaneous administration in immunodeficiency patients naive to replacement therapy
por: Koterba, Alan P, et al.
Publicado: (2014)

Subcutaneous immunoglobulin therapy for adult patients with primary immunodeficiency disease: Qatar experience
por: Thalappil, Sherin, et al.
Publicado: (2023)

Facilitated Subcutaneous Immunoglobulin Replacement Therapy in Clinical Practice: A Two Center, Long-Term Retrospective Observation in Adults With Primary Immunodeficiencies
por: Wiesik-Szewczyk, Ewa, et al.
Publicado: (2020)

Awareness of thrombotic disease during lockdown: an unusual consequence of the COVID-19 pandemic
por: Speletas, Matthaios
Publicado: (2021)

Implications to payers of switch from hospital-based intravenous immunoglobulin to home-based subcutaneous immunoglobulin therapy in patients with primary and secondary immunodeficiencies in Canada
por: Gerth, William C, et al.
Publicado: (2014)

Implications to payers of switch from hospital-based intravenous immunoglobulin (IVIg) to home-based subcutaneous immunoglobulin (SCIg) therapy in patients with primary immunodeficiencies (PID) and secondary immunodeficiencies (SID) in Canada
por: Gerth, William C, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_vkb28h589jp1pggisv1c2kbubf